Trials / Sponsors / Cellenkos, Inc.
Cellenkos, Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | CK0801 for Treatment of Aplastic Anemia Aplastic Anemia | Phase 2 | 2026-08-03 |
| Active Not Recruiting | Regulatory T Cells for Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis | Phase 1 | 2023-04-03 |
| Recruiting | Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs Myelofibrosis | Phase 1 | 2022-12-27 |
| Withdrawn | A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS) Guillain-Barré Syndrome | Phase 1 | 2022-11-01 |
| Completed | REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia COVID19, ARDS | Phase 1 | 2020-09-29 |
| Active Not Recruiting | A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF) Bone Marrow Disease | Phase 1 | 2019-05-30 |